Close Menu

NEW YORK (GenomeWeb) – LifeMap Sciences today announced an agreement to promote Toldot Genetics' products to its users in academia, research hospitals, and biopharmaceutical companies.

The partners also said they will collaborate to optimize Toldot's genetic variation analysis tools using LifeMap's GeneCards database.

LifeMap, a BioTime subsidiary, is the exclusive marketer of genetic database tools developed by the Weizmann Institute of Science in Rehovot, Israel, including the GeneCards human gene database and MalaCards human disease database.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.